Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.64M Buy
18,327
+6,090
+50% +$2.08M 4.93% 3
2026
Q1
$4.31M Buy
12,237
+12,018
+5,488% +$4.28M 3.86% 3
2025
Q4
$71.7K Sell
219
-520
-70% -$165K 0.11% 89
2025
Q3
$208K Sell
739
-35
-5% -$10.2K 0.03% 216
2025
Q2
$216K Buy
774
+111
+17% +$31.4K 0.03% 195
2025
Q1
$207K Buy
+663
New +$196K 0.03% 175

Other funds holding AMGN

Fountainhead AM's AMGN Position: Q2 2026 in Review

Fountainhead AM increased its Amgen (AMGN) stake by 50% in Q2 2026, buying an estimated $2.08M and bringing the position to 18,327 shares worth $6.64M. The position accounts for 4.93% of the portfolio, ranked #3.

Fountainhead AM first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fountainhead AM held 18,327 shares of Amgen worth $6.64M as of Q2 2026.
  • Fountainhead AM bought 6,090 Amgen shares in Q2 2026, an estimated $2.08M.
  • Amgen made up 4.93% of Fountainhead AM's portfolio in Q2 2026, its #3 holding.
  • Fountainhead AM first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.